Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
Clinical trial NCT06147986 · RECRUITING
Trial details
- NCT number
- NCT06147986
- Sponsor
- Ever Supreme Bio Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-24
- Primary completion
- 2027-06-24
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.